SynthesisFrontiers in immunology2026

Efficacy and safety of disease-modifying oral drugs in treatment of relapsing-remitting multiple sclerosis: systematic review and network meta-analysis.

Yonghong Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.